Table 3:
Treatment and Follow-Up Information
| Case | Treatment | Clinical course | Outcome | Follow-up (months) |
|---|---|---|---|---|
| 1 | Surgery + XRT + chemo (VDC/IE) | No residual disease | NED | 1 |
| 2 | Surgery, additional treatment pending | No residual disease | NED | 0 |
| 3 | Surgery, additional treatment pending | No residual disease | NED | 0 |
| 4 | Surgery + chemo (VDC/IE) | No residual disease | DWD | 3 |
| 5 | Surgery, additional treatment pending | No residual disease | NED | 1 |
| 6 | Surgery + XRT + chemo (doxorubicin) | No residual disease | NED | 13 |
| 7 | Surgery + XRT + chemo (carboplatin/etoposide) | Persistent disease following initial therapy | AWD | 8 |
| 8 | Surgery + XRT + chemo (VDC/IE) | No residual disease | NED | 19 |
| 9 | Surgery + XRT + chemo (initially carboplatin/paclitaxel then VDC/IE) | No residual disease | NED | 24 |
| 10 | Surgery, additional treatment pending | No residual disease | NED | 0 |
VDC/IE = alternating vincristine + doxorubicin + cyclophosphamide and ifosfamide + etoposide; XRT = external beam radiation therapy; AWD = alive with disease; chemo = systemic chemotherapy; DWD = dead with disease; NED = no evidence of disease